1. Clinical characteristics and tumor markers in ischemic stroke patients with active cancer
- Author
-
Naoki Oyama, Tomohisa Nezu, Naohisa Hosomi, Yoshiki Yagita, Yuko Morimoto, Tsuyoshi Torii, Shiro Aoki, Naoto Kinoshita, Hirofumi Maruyama, Tomohiko Ohshita, Hiroyuki Naito, Hiroki Ueno, Takeshi Yoshida, Teppei Kamimura, Yuji Shiga, Takashi Kurashige, Daisuke Kuzume, and Tomohito Sugiura
- Subjects
medicine.medical_specialty ,CA-19-9 Antigen ,Gastroenterology ,Carcinoembryonic antigen ,Neoplasms ,Internal medicine ,D-dimer ,Biomarkers, Tumor ,Internal Medicine ,medicine ,Humans ,Thrombophilia ,Ischemic Stroke ,biology ,business.industry ,Cancer ,Atrial fibrillation ,medicine.disease ,Carcinoembryonic Antigen ,Stroke ,C-Reactive Protein ,Quartile ,CA-125 Antigen ,Ischemic stroke ,Emergency Medicine ,biology.protein ,Adenocarcinoma ,business ,Dyslipidemia - Abstract
Cancer-associated ischemic stroke (CAS) refers to a hypercoagulation disorder related to malignant tumors, especially adenocarcinoma. Carbohydrate antigen (CA) 125 is a mucinous serum marker that might reflect hypercoagulation status, but the association between CA 125 and CAS is unclear across various types of cancer. The aim of this study was to investigate the associations among tumor markers, coagulation markers, and clinical factors in acute ischemic stroke (AIS) patients with active cancer. Consecutive AIS patients with active cancer (a diagnosis or ongoing active therapy for cancer within 6 months) were prospectively enrolled at four hospitals. D-dimer, C-reactive protein (CRP), carcinoembryonic antigen (CEA), CA19-9, and CA 125 levels were measured. Of 120 AIS patients with active cancer, 47 were diagnosed with CAS. CA 125 had the strongest correlations with D-dimer and CRP (ρ = 0.543, p
- Published
- 2021
- Full Text
- View/download PDF